Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TGF-β, Sca-1, and Mammary Cell Plasticity
2026-09-07
The 2020 Scientific Reports study shows that TGF-β controls Sca-1 expression while reshaping lineage plasticity and tumor-initiating potential in pre-neoplastic and mammary cancer models. Its central contribution is the distinction between endogenous Smad2/3/4-dependent regulation and exogenous TGF-β-driven Sca-1 loss that can occur independently of Smad2/3, an important consideration for interpreting stem-cell markers and pathway inhibition experiments.
-
Partial BACE Inhibition Preserves Synaptic Transmission
2026-09-07
Satir et al. show that moderate β-secretase inhibition can reduce amyloid β secretion without disrupting synaptic transmission in primary cortical neuron cultures. The study defines an experimentally useful safety window for Aβ-lowering strategies while cautioning that stronger BACE inhibition may impair neuronal function.
-
Melatonin–Sacchachitin Hydrogel for Atopic Dermatitis
2026-09-05
The reference study developed a melatonin-loaded sacchachitin nanofiber hydrogel and evaluated it in a DNCB-induced NC/Nga mouse model of atopic dermatitis. Its main contribution is to combine a biocompatible structural scaffold with melatonin-driven anti-inflammatory activity, while preserving relevant hydrogel stability and mechanical properties.
-
Infigratinib Reverses ABCB1-Linked Drug Resistance
2026-09-04
The reference study shows that infigratinib (BGJ 398), a pan-FGFR inhibitor, can restore paclitaxel and doxorubicin sensitivity in ABCB1-overexpressing tumor cells by impairing drug efflux rather than reducing transporter expression. Its comparison with PD 173074 highlights that FGFR kinase inhibition and multidrug-resistance reversal are separable pharmacologic properties that require independent testing.
-
Triiodothyronine T3 Workflows for Adipose Research
2026-09-04
Build reproducible T3 experiments for thyroid hormone receptor activation, beige adipocyte thermogenesis, and cellular metabolism assays. This workflow distinguishes direct endocrine signaling from SETD7-driven adipose remodeling while providing practical preparation, dosing, and troubleshooting guidance.
-
gamma-Glu-Cys (γ-Glu-Cys) Lab Guide
2026-09-03
A scenario-based guide to using gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, in glutathione metabolism research, glutathione synthetase enzyme assays, and carefully controlled cell experiments. It connects product specifications with practical controls, storage decisions, interpretation limits, and evidence from γ-glutamyl peptide research.
-
ApexPrep DNA Plasmid Miniprep Kit Guide
2026-09-03
A scenario-based guide to using the ApexPrep DNA Plasmid Miniprep Kit, SKU A5001, for dependable plasmid preparation in viability, proliferation, cytotoxicity, and transfection workflows. It connects alkaline lysis, practical quality control, and AML research considerations without overstating kit validation.
-
Live-Dead Bacterial Staining Kit for Nanomaterials
2026-09-02
Use the Live-Dead Bacterial Staining Kit to distinguish membrane-intact bacteria from membrane-compromised cells during nanoparticle antibacterial studies. Its two-channel readout adds spatial and mechanistic context to culture-based bacterial viability assay results, helping researchers optimize dose, exposure time, and imaging controls.
-
Spatial Lipid Remodeling in Postoperative Cognition
2026-09-02
A rat cardiopulmonary bypass model combined with Barnes maze phenotyping, mass spectrometry imaging, enzyme mapping, and electron microscopy to define hippocampal lipid changes associated with postoperative cognitive dysfunction. The study links CA1 lipid remodeling with synaptic abnormalities and reports that intervention with DHA and myriocin reduced the cognitive phenotype, supporting lipid metabolism as a testable target rather than merely a biomarker.
-
AT13387 Hsp90 Inhibitor Workflow for Cancer Research
2026-09-01
Build a mechanism-driven cancer biology workflow around AT13387, from Hsp90 client-protein loss to apoptosis and cell-release phenotyping. The approach also translates a recent norovirus–NINJ1 discovery into carefully bounded assay controls without confusing viral secretion biology with anticancer mechanism.
-
GDC-0941: From PI3K Biology to Translational Strategy
2026-09-01
A mechanistic and strategic guide to using GDC-0941 to interrogate PI3K/Akt signaling, therapy resistance, cancer stem cell biology, and translational assay design.
-
Triacetin: Workflows for Metabolic and GBM Research
2026-08-31
Triacetin, or glyceryl triacetate, supports distinct experimental workflows spanning glioblastoma cytotoxicity, adipogenesis research, and ocular formulation screening. This practical guide connects mechanism-aware assay design with concentration selection, controls, and troubleshooting for more reproducible results.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-08-31
Cy5 NHS ester(Et) is a water-soluble, amine-reactive fluorescent dye for covalent labeling of proteins, peptides, and other biomolecules. It is suited to aqueous or DMSO-based labeling workflows, but should not be used in ethanol-based protocols or for long-term storage of prepared solutions.
-
NU7441 and DNA-PK: From Repair to Translation
2026-08-30
NU7441, also known as KU-57788, is more than a potent DNA-PK inhibitor: it is a mechanistic probe for connecting double-strand break repair, cell-cycle behavior, and emerging links between cytosolic DNA and TDP-43 homeostasis. This article outlines a translational framework for using NU7441 in DNA repair research, oncology research, and exploratory neurobiology while distinguishing evidence from hypothesis.
-
Erlotinib: A Causal Map of EGFR–SCUBE3 Biology
2026-08-29
Erlotinib (NSC 718781) is more than an EGFR inhibitor: it is a practical perturbation tool for separating receptor-proximal signaling from SCUBE3-associated resistance and immune suppression. This article presents an assay framework that connects biochemical potency with translational cancer-model decisions.